Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiko Kitano

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Ophthalmology|April 3, 2004
Limitation of Scheimpflug videophotography system in quantifying posterior capsule opacification after intraocular lens implantationYoshikazu Tanaka, Satoshi Kato, Kazunori Miyata, et al.
Japanese Journal of Ophthalmology|March 10, 2023
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Shigehiko Kitano, Nahoko Ogata, et al.
American Journal of Ophthalmology|November 5, 2003
Diabetic retinopathy with repeated amaurosis fugax caused by orthostatic hypotensionTatsuya Mimura, Hideharu Funatsu, Shigehiko Kitano, et al.
Scientific Reports|November 9, 2016
Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording deviceMotonobu Fukuo, Mineo Kondo, Akira Hirose, et al.
Ophthalmology|September 15, 2005
Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathyTatsuya Mimura, Hideharu Funatsu, Yasuko Uchigata, et al.
American Journal of Ophthalmology|June 6, 2003
Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitusTatsuya Mimura, Hideharu Funatsu, Yasuko Uchigata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2021
Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)Taiji Sakamoto, Masahiko Shimura, Shigehiko Kitano, et al.
Scientific Reports|October 18, 2019
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter StudyKei Takayama, Hideaki Someya, Hiroshi Yokoyama, et al.
Plos One|October 8, 2021
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathyKei Takayama, Hideaki Someya, Hiroshi Yokoyama, et al.
Journal of Ophthalmology|December 31, 2019
Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic RetinopathyHideaki Someya, Kei Takayama, Masaru Takeuchi, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Ophthalmology|April 3, 2004
Limitation of Scheimpflug videophotography system in quantifying posterior capsule opacification after intraocular lens implantationYoshikazu Tanaka, Satoshi Kato, Kazunori Miyata, et al.
Japanese Journal of Ophthalmology|March 10, 2023
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Shigehiko Kitano, Nahoko Ogata, et al.
American Journal of Ophthalmology|November 5, 2003
Diabetic retinopathy with repeated amaurosis fugax caused by orthostatic hypotensionTatsuya Mimura, Hideharu Funatsu, Shigehiko Kitano, et al.
Scientific Reports|November 9, 2016
Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording deviceMotonobu Fukuo, Mineo Kondo, Akira Hirose, et al.
Ophthalmology|September 15, 2005
Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathyTatsuya Mimura, Hideharu Funatsu, Yasuko Uchigata, et al.
American Journal of Ophthalmology|June 6, 2003
Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitusTatsuya Mimura, Hideharu Funatsu, Yasuko Uchigata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2021
Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)Taiji Sakamoto, Masahiko Shimura, Shigehiko Kitano, et al.
Scientific Reports|October 18, 2019
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter StudyKei Takayama, Hideaki Someya, Hiroshi Yokoyama, et al.
Plos One|October 8, 2021
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathyKei Takayama, Hideaki Someya, Hiroshi Yokoyama, et al.
Journal of Ophthalmology|December 31, 2019
Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic RetinopathyHideaki Someya, Kei Takayama, Masaru Takeuchi, et al.
Pageof 5